Protein kinase C regulates α2A/D-adrenoceptor constitutive activity

Pharmacology

Volumn 71, Issue 2, 2004, Pages 80-90

  Zhu, Qingbing ^a   Qi, Lai Jun ^b   Shi, Anguo ^a   Abou Samra, Abdul ^b   Deth, Richard C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adrenoceptors; Epinephrine; G protein coupled receptors; Protein kinase C; Rauwolscine

Indexed keywords

PROTEIN KINASE C; PROTEINASE INHIBITOR; RAUWOLFIA ALKALOID;

ARTICLE; BINDING ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR BINDING;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIBODIES; EPINEPHRINE; GTP-BINDING PROTEINS; HUMANS; MUTATION, MISSENSE; PC12 CELLS; PROTEIN CONFORMATION; PROTEIN KINASE C; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ANALYSIS, PROTEIN; SULFUR RADIOISOTOPES; THREONINE; TRANSCRIPTION FACTORS; TRANSFECTION; YOHIMBINE;

EID: 2342530465     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076944     Document Type: Article

References (39)

1. Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana G: Requirement for rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 1996;74:768-769.
2. 2 adrenergic receptor. Proc Natl Acad Sci USA 2001;98:5997-6002.
3. 2A- adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J Biol Chem 1991;266:11025-11029.
4. i-activator sequence of the alpha 2-adrenergic receptor and have a Phe substitute in the G protein-activator sequence motif. FEBS Lett 1992;311:29-32.
5. Liu J, Conklin BR, Blin N, Yun J, Wess J: Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc Natl Acad Sci USA 1995;92:11642-11646.
6. Sheikh SP, Vilardarga JP, Baranski TJ, Lichtarge O, Iiri T, Meng EC, Nissenson RA, Bourne HR: Similar structures and shared switch mechanisms of the beta-2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. J Biol Chem 1999;274:17033-17041.
7. 2A/D-adrenoceptors. J Pharmacol Exp Ther 2000;292:664-671.
8. Okamoto T, Nishimoto I: Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem 1992;267:8342-8346.
9. Eason MG, Liggett SB: Identification of a Gs coupling domain in the amino terminus of the third intracellular loop of the alpha 2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling. J Biol Chem 1995;270:24753-24760.
10. Lembo PMC, Ghahremani MH, Morris SJ, Albert PR: A conserved threonine residue in the second intracellular loop of the 5-hydroxytryptamine 1A receptor directs signaling specificity. Mol Pharmacol 1997;52:164-171.
11. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ: Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 1992;267:1430-1433.
12. Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S: Constitutively active mutants of the alpha 2-adrenergic receptor. J Biol Chem 1993;268:16483-16487.
13. Samama P, Cotecchia S, Costa T, Lefkowitz RJ: A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993;268:4625-4636.
14. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr: A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993;365:639-642.
15. Kopp P, van Sande J, Parma J, Dprez L, Gerber H, Joss E, Jameson JL, Dumont J, Vassart G: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995;332:150-154.
16. Strader CD, Sigal IS, Dixon RAF: Structural basis of β-adrenergic receptor function. FASEB J 1989;3:1825-1832.
17. Neubig RR, Gantzos RD, Thomsen WJ: Mechanism of agonist and antagonist binding to alpha 2 adrenergic receptors: Evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 1988;27:2374-2384.
18. Costa T, Lang J, Gless C, Herz A: Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: Specific regulation by antagonists and sodium ions. Mol Pharmacol 1990;37:383-394.
19. Jagadeesh G, Cragoe EJ Jr, Deth RC: Modulation of bovine aortic alpha-2 receptors by Na+, 5′-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: Evidence of receptor G-protein precoupling. J Pharmacol Exp Ther 1990;252:1184-1196.
20. Wang Z, Bilsky EJ, Porreca F, Sadee W: Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 1994;54:PL339-PL350.
21. 2D adrenergic receptor activation of G proteins: Evidence for a precoupled R/G state. Mol Pharmacol 1994;45:524-531.
22. 2D adrenergic receptors. Pharmacol 2000;61:14-21.
23. Zoller MJ, Smith M: Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol 1983;100:468-500.
24. Kunkel TA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985;82:488-492.
25. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M: Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000;289:739-745.
26. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC: Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 1992;11:1-20.
27. Lanier SM, Downing S, Duzic E, Homcy CJ: Isolation of rat genomic clones encoding subtypes of the α-2-adrenergic receptor. J Biol Chem 1991;266:10470-10478.
28. Simonds WF, Goldsmith PK, Codina J, Unson CG, Spiegel AM: Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: In situ identification with G alpha C-terminal antibodies. Proc Natl Acad Sci USA 1989;86:7809-7813.
29. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989;159:548-553.
30. Herbert JM, Augereau JM, Gleye J, Maffrand: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990;172:993-999.
31. Lee SK, Qing WG, Mar W, Luyengi L, Mehta RG, Kawanishi K, Fong HH, Beecher CW, Kinghorn AD, Pezzuto JM: Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C. J Biol Chem 1998;273:19829-19833.
32. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamell L, Charon D, Kirolovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-15781.
33. ++ dependent protein kinase. Biochem Biophys Res Commun 1986;135:397-402.
34. Sato M, Kataoka R, Dingus J, Wilcox M, Hildebrandt JD, Lanier SM: Factors determining specificity of signal transduction by G-protein-coupled receptors: Regulation of signal transfer from receptor to G-protein. J Biol Chem 1995;270:15269-15276.
35. Duzic E, Lanier SM: Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. III. Coupling of alpha 2-adrenergic receptor subtypes in a cell type-specific manner. J Biol Chem 1992;267:24045-24052.
36. Wade SM, Lan K, Moore DJ, Neubig RR: Inverse agonist activity at the alpha(2A)-adrenergic receptor. Mol Pharmacol 2001;59:532-542.
37. Pauwels PJ, Tardif S, Wurch T, Colpaert FC: Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: Evidence for inverse agonism. J Pharmacol Exp Ther 2000;292:654-663.
38. Sharma A, Kramer ML, Wick PF, Liu D, Chari S, Shim S, Tan W, Ouellette D, Nagata M, DuRand CJ, Kotb M, Deth RC: D4 Dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia. Mol Psychiatry 1999;4:235-246.
39. Zhao R, Chen Y, Tan W, Waly M, Sharma A, Stover P, Rosowsky A, Malewicz B, Deth RC: Relationship between dopamine-stimulated phospholipid methylation and the single-carbon folate pathway. J Neurochem 2001;78:788-796.